"What you want to avoid is panic. What you want to teach yourself is that you deserve better than lying alone in a dark room, imagining yourself buried." || Diana Spechler for NYT's Opinionator: 10 Things I'd Tell My Former (Medicated) Self, the final installment in Going Off, a series of essays recounting the challenges Spechler has faced in gradually discontinuing her regimen of psychiatric medications.
For the past few years, a small group of psychiatrists, researchers, educators, and game designers have run a quiet but intense footrace to become the first to earn FDA approval for a medically sound, prescription-strength video game for ADHD. That’s not a metaphor. They are seeking approval for a game that a doctor can actually prescribe..In this excerpt from his new book, posted on Medium, journalist Greg Toppo discusses a variety of new neurogames and how they may in the future treat conditions like ADHD and anxiety, strengthen skills like multitasking and mindfulness, and reduce the need for pharmaceutical interventions for children. (Fair warning, the article has an animated header image that may annoy, so you may want to scroll right on down past it before you start reading.)
Falling STAR*D?: It is common practice for psychiatrists to switch depressive patients between different antidepressants if their current drug does not evince a symptomatic response. Despite clinical wisdom supporting this, little empirical, controlled evidence exists to direct “switching” protocols (e.g. if a patient with Z characteristics is on drug X, is it usually better to switch to drug A, B, or C? Will switching help at all?) in the psychopharmacological treatment of depression. The NIMH-funded STAR*D (Sequenced Alternatives to Relieve Depression) study aimed to address these questions of treatment direction in a very large (n>4000), “real-world” sample using a multi-phase treatment plan with different drugs (and cognitive therapy) at every step to maximize chances of eventual remission. Overall, the NIMH reported that about 67% of patients eventually achieved remission, with few differences in effectiveness between different types of treatment at each step. However, researchers and commentators have raised concerns regarding inconsistent reporting of outcomes, after-the-fact changes in study design and analysis, and other issues that may have inflated, partially invalidated, or misrepresented widely reported treatment outcomes. These inequities may also have implications for the secondary moderator analyses (i.e. does trait A predict switching to X or Y is better?) that were a major reason for the study. [more inside]
Suppose you have a problem with your thinking, your mood, or your relationships. Come in, sit down, and let the internet help. Meet MoodGym and its newer sister site, e-couch. [more inside]
Pills for Problems: The British have taken steps to restrict the use of some antidepressants. Breggin and others have been warning us for some time now about the many problems with medicating behavior. The Big Picture: Aren't "medications" (legal or not) used for behavioral problems just an excuse for us not controlling ourselves?
As if you weren't depressed enough, now the world knows you're taking Prozac